Vertex Pharmaceuticals | Eiendeler



Assets Endring Dato
AbbVie USD 135.16B 8.26B 2024-12
Acadia Pharmaceuticals USD 1.19B 210.89M 2024-12
Agios Pharmaceuticals USD 1.56B 107.68M 2025-03
Alnylam Pharmaceuticals USD 4.21B 26.17M 2025-03
Amgen USD 89.37B 2.47B 2025-03
Arrowhead Research USD 1.01B 126.11M 2024-12
Biogen USD 28.03B 16.2M 2025-03
BioMarin Pharmaceutical USD 7.15B 158.07M 2025-03
Bristol-Myers Squibb USD 92.43B 176M 2025-03
Gilead Sciences USD 56.43B 2.56B 2025-03
Incyte USD 5.75B 305.04M 2025-03
Insmed USD 2.03B 27.74M 2024-12
Ionis Pharmaceuticals USD 2.81B 190.73M 2025-03
J&J USD 193.67B 13.57B 2025-03
Merck USD 117.11B 426M 2024-12
Moderna USD 12.7B 1.44B 2025-03
Neurocrine Biosciences USD 3.72B 183.7M 2024-12
Novartis USD 102.25B 1.28B 2024-12
Pfizer USD 213.4B 6.08B 2024-12
PTC Therapeutics USD 1.71B 137.21M 2024-12
Regeneron Pharmaceuticals USD 37.55B 214.2M 2025-03
Roche Holding CHF 101.8B 6.02B 2024-12
Sanofi 131.89B 906M 2025-03
Sarepta Therapeutics USD 3.96B 363.24M 2024-12
Ultragenyx Pharmaceutical USD 1.5B 34.91M 2024-12
United Therapeutics USD 7.74B 379.9M 2025-03
Vertex Pharmaceuticals USD 22.53B 293M 2024-12



Vertex Pharmaceuticals Eiendeler - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2025.